YuanBio
圆因生物
YuanBio
Biotech/Healthcare
Founded in Beijing in April 2021, Circular RNA Biotech focuses on developing novel vaccines and innovative therapies using circular RNA technology. The company has built an extensive pipeline of preventive and therapeutic drug candidates aimed at addressing unmet clinical needs.
Latest round: Series A (2022)
Source: ChinaBulls — chinabulls.com
Last updated 2022-06-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.